Drawing for ACELIS CONNECTED HEALTH

USPTO serial 88153643

ACELIS CONNECTED HEALTH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BROWNING, LUKE CASH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ACELIS CONNECTED HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michele H. Bowman

Michele H. Bowman Abbott Laboratories100 Abbott Park RoadAbbott Park, IL 60064UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Providing temporary use of non-downloadable web based software for remote patient medical monitoring; software as a service (SAAS) services featuring software for remote patient medical monitoring; providing temporary use of non-downloadable web based software for remote monitoring, collecting, transmitting and managing of data indicative of the health or condition of an individual or group of individuals and of data indicative of medical instrument functioning, for use with medical diagnostics instruments in connection with remote patient medical monitoring; software as a service (SAAS) services featuring software for remote monitoring, collecting, transmitting and managing of data indicative of the health or condition of an individual or group of individuals and of data indicative of medical instrument functioning, for use with medical diagnostics instruments in connection with remote patient medical monitoring; providing a web based patient portal featuring technology for accessing medical and healthcare information for use in connection with remote patient medical monitoring; providing a web based medical provider portal featuring technology for accessing medical and healthcare information for use in connection with remote patient medical monitoring; technical support services, namely, troubleshooting in the nature of diagnosing problems with medical apparatus and instruments used in remote patient medical monitoring; providing temporary use of non-downloadable web based software for managing and documenting medical therapies; software as a service (SAAS) services featuring software for managing and documenting medical therapies; providing temporary use of non-downloadable web based software for use in collecting and analyzing health data and testing results, providing temporary use of non-downloadable web based software for monitoring, medical conditions in the field of remote patient medical monitoring; software as a service (SAAS) services featuring software for use in collecting, and analyzing health data and testing results, dosing, managing, treating, and monitoring medical conditions in the field of remote patient medical monitoring; providing temporary use of non-downloadable web based software for the management and documentation of disease states; software as a service (SAAS) services featuring software for the management, and documentation of disease states; providing temporary use of non-downloadable web based software for medical provider and patient communication in the field of remote patient medical monitoring; software as a service (SAAS) services featuring software for medical provider and patient communication in the field of remote patient medical monitoring; providing temporary use of non-downloadable web based software for medical providers to electronically manage, monitor and process patient health data in the field of remote patient medical monitoring; software as a service (SAAS) services featuring software for medical providers to electronically manage and process patient health data in the field of remote patient medical monitoringACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 13, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 13, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 30, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 28, 2021EX3GSOU EXTENSION 3 GRANTED—
Apr 28, 2021EXT3SOU EXTENSION 3 FILED—
Apr 28, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 7, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 5, 2020EX2GSOU EXTENSION 2 GRANTED—
Nov 5, 2020EXT2SOU EXTENSION 2 FILED—
Nov 5, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 25, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 25, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 25, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 25, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 25, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 2, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 30, 2020EX1GSOU EXTENSION 1 GRANTED—
Apr 30, 2020EXT1SOU EXTENSION 1 FILED—
Apr 30, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 12, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 17, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 17, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 28, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 15, 2019ALIEASSIGNED TO LIE—
Aug 8, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 1, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Aug 1, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 1, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 1, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 18, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 17, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 17, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 17, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 17, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 17, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2019DOCKASSIGNED TO EXAMINER—
Oct 25, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 24, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 16, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance